Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 2

Grady Wulff
February 23, 2023

Continue on to learn about the remaining stocks, Microba Life Sciences (ASX:MAP) and Monash IVF (ASX:MVF), as well as what to expect from these companies in 2023.

In this video, Dr. Tara discusses:
– (0:34) Impacts of Ferring’s FDA approval on Microba
– (5:30) Drivers behind Microba’s increase in revenue
– (7:12) What 2023 looks like for Monash IVF
– (8:39) Monash IVF’s rating
– (11:45) Monash IVF’s impact from legal action

Note: This interview was filmed on 7 February 2023.

Morning Bell 24 May

Grady Wulff
May 24, 2023

Morning Bell 23 May

Grady Wulff
May 23, 2023

Weekly Wrap 12 May

Grady Wulff
May 12, 2023

Morning Bell 12 May

Sophia Mavridis
May 12, 2023

Morning Bell 11 May

Grady Wulff
May 11, 2023

Morning Bell 10 May

Grady Wulff
May 10, 2023

Morning Bell 9 May

Sophia Mavridis
May 9, 2023

Morning Bell 8 May

Grady Wulff
May 8, 2023

Weekly Wrap 5 May

Sophia Mavridis
May 5, 2023

Morning Bell 4 May

Grady Wulff
May 4, 2023

Morning Bell 3 May

Sophia Mavridis
May 3, 2023